AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimip MF 1mg/1000mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Roussel Laboratories Pvt Ltd

Salt Composition

Glimepiride (1mg) + Metformin (1000mg)

Overview Glimip MF 1mg/1000mg Tablet SR

Diabetic patients utilizing the dual-action formulation Glimip MF 1mg/1000mg SR tablets, classified as an anti-diabetic agent, should adhere to their physician's prescribed dosage and administration schedule. This medication, a combination therapy for adult type 2 diabetes, effectively regulates blood glucose. Consistent daily intake, ideally with meals, maximizes therapeutic efficacy. Dosage adjustments may be necessary based on individual blood sugar responses and should be determined solely by your healthcare provider. Discontinuation without medical consultation poses significant risks, potentially leading to elevated blood sugar, increasing the likelihood of complications such as nephropathy, retinopathy, neuropathy, and peripheral vascular disease. This medication forms part of a comprehensive diabetes management plan, encompassing dietary modifications, regular physical activity, and weight management as recommended by your doctor. Commonly reported adverse effects include hypoglycemia (low blood sugar). Recognizing symptoms like tremors, sweating, dizziness, and headaches is crucial for prompt management. Regular mealtimes and readily available fast-acting glucose sources are essential preventative measures. Alcohol consumption should be minimized due to its potential to exacerbate hypoglycemia. Additional side effects may include gastrointestinal upset (nausea, diarrhea, abdominal pain), altered taste perception, headaches, upper respiratory infections, and weight gain. Glimip MF 1mg/1000mg SR tablets are contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Individuals with a history of cardiovascular disease should discuss suitability with their physician prior to commencing treatment. Pregnant or lactating women require specific medical guidance before initiating therapy. Regular blood glucose monitoring, along with periodic blood tests to assess hematological parameters and liver function, are recommended under your physician's supervision.

Uses of Glimip MF 1mg/1000mg Tablet SR

Managing type 2 diabetes

Major Benefits of Glimip MF 1mg/1000mg Tablet SR:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Glimip MF 1mg/1000mg Extended-Release Tablet should be administered with a meal.

Common Side effects of Glimip MF 1mg/1000mg Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimip MF 1mg/1000mg Tablet SR:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Glimip MF 1mg/1000mg Extended-Release Tablet with food.

How Glimip MF 1mg/1000mg Tablet SR works:

Glimip MF 1mg/1000mg Extended-Release tablets contain glimepiride and metformin, two antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glimip MF 1mg/1000mg Tablet SR with alcohol is contraindicated due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glimip MF 1mg/1000mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Prolonged release Glimip MF 1mg/1000mg tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant harm from this medication.

DrivingDrivingCAUTION

Impaired driving is possible with excessively low or high blood glucose levels. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Glimip MF 1mg/1000mg SR tablets, as dosage modification may be necessary. Consult your physician for guidance. Glimip MF 1mg/1000mg SR tablets are contraindicated in individuals with severe kidney disease. Regular monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glimip MF 1mg/1000mg Tablet SR cautiously, potentially requiring dosage modification. A physician's consultation is advised. Individuals with mild to moderate hepatic dysfunction typically commence treatment with a low Glimip MF 1mg/1000mg Tablet SR dose; however, its use is contraindicated in those with severe liver disease.

What if you forget to take Glimip MF 1mg/1000mg Tablet SR :

Should you forget a Glimip MF 1mg/1000mg SR tablet, take it immediately upon remembrance. If, however, your next dose is imminent, omit the missed tablet and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimip MF 1mg/1000mg Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glimip MF 1mg/1000mg Tablet SR

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Glimip MF 1mg/1000mg Tablet SR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare but potentially harmful side effect is more likely in patients with kidney disease, older adults, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these symptoms, discontinue Glimip MF 1mg/1000mg Tablet SR and seek immediate medical attention.
Glimip MF 1mg/1000mg SR tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. This medication is unsuitable for type 1 diabetes.
Glimip MF 1mg/1000mg Tablet SR may cause common side effects such as low blood sugar, taste changes, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Prolonged use of Glimip MF 1mg/1000mg SR tablets can lead to vitamin B12 deficiency by impairing its absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary difficulties, cognitive changes, and ataxia. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Glimip MF 1mg/1000mg SR tablets can cause hypoglycemia (low blood sugar). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, and anxiety or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Glimip MF 1mg/1000mg SR tablets with alcohol is unsafe. This combination can dangerously lower blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Glimip MF 1mg/1000mg Tabl...
49
MRP 60
18% off